TEAS RF New Application

ZYNRELEF

Heron Therapeutics, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)

Trademark/Service Mark Application, Principal Register

Serial Number: 87718146
Filing Date: 12/12/2017

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 87718146
MARK INFORMATION
*MARK ZYNRELEF
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ZYNRELEF
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Heron Therapeutics, Inc.
*STREET 4242 Campus Point Court, Suite 200
*CITY San Diego
*STATE
(Required for U.S. applicants)
California
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92121
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances, namely, anesthetics for surgical purposes; anesthetics for surgical use; inhalant anesthetics; local anesthetics; topical anesthetics; general anesthetics; anti-inflammatory preparations; anti-inflammatory ointments; analgesic preparations; preparations for the relief of pain; anesthetics for peri-operative and post-operative use; pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of pain
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Beth M. Goldman
ATTORNEY DOCKET NUMBER 21539-6000
FIRM NAME Orrick, Herrington & Sutcliffe LLP
INTERNAL ADDRESS IP Prosecution Department
STREET 2050 Main Street, Suite 1100
CITY Irvine
STATE California
COUNTRY United States
ZIP/POSTAL CODE 92614-8255
PHONE 415-773-5700
FAX 415-773-5759
EMAIL ADDRESS ipprosecutionsf@orrick.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Betsy Wang Lee, Eileen Z. Aghnami, Scott Lonardo, Chris Civil, Thomas H. Zellerbach, Kristin S. Cornuelle, Diana M. Rutowski, Jane E. Hinkson, Peter D. Vogl
CORRESPONDENCE INFORMATION
NAME Beth M. Goldman
FIRM NAME Orrick, Herrington & Sutcliffe LLP
INTERNAL ADDRESS IP Prosecution Department
STREET 2050 Main Street, Suite 1100
CITY Irvine
STATE California
COUNTRY United States
ZIP/POSTAL CODE 92614-8255
PHONE 415-773-5700
FAX 415-773-5759
*EMAIL ADDRESS ipprosecutionsf@orrick.com; beth.goldman@orrick.com; blee@orrick.com; eaghnami@orrick.com; aparker@orrick.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /Thomas Ottoboni/
SIGNATORY'S NAME Thomas Ottoboni
SIGNATORY'S POSITION Senior VP
SIGNATORY'S PHONE NUMBER 415-773-5700
DATE SIGNED 12/12/2017



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)


Trademark/Service Mark Application, Principal Register

Serial Number: 87718146
Filing Date: 12/12/2017

To the Commissioner for Trademarks:

MARK: ZYNRELEF (Standard Characters, see mark)
The literal element of the mark consists of ZYNRELEF.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Heron Therapeutics, Inc., a corporation of Delaware, having an address of
      4242 Campus Point Court, Suite 200
      San Diego, California 92121
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations and substances, namely, anesthetics for surgical purposes; anesthetics for surgical use; inhalant anesthetics; local anesthetics; topical anesthetics; general anesthetics; anti-inflammatory preparations; anti-inflammatory ointments; analgesic preparations; preparations for the relief of pain; anesthetics for peri-operative and post-operative use; pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of pain
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


The applicant's current Attorney Information:
      Beth M. Goldman and Betsy Wang Lee, Eileen Z. Aghnami, Scott Lonardo, Chris Civil, Thomas H. Zellerbach, Kristin S. Cornuelle, Diana M. Rutowski, Jane E. Hinkson, Peter D. Vogl of Orrick, Herrington & Sutcliffe LLP
      IP Prosecution Department
      2050 Main Street, Suite 1100
      Irvine, California 92614-8255
      United States
      415-773-5700(phone)
      415-773-5759(fax)
      ipprosecutionsf@orrick.com (authorized)
The attorney docket/reference number is 21539-6000.
The applicant's current Correspondence Information:
      Beth M. Goldman
      Orrick, Herrington & Sutcliffe LLP
      IP Prosecution Department
      2050 Main Street, Suite 1100
      Irvine, California 92614-8255
      415-773-5700(phone)
      415-773-5759(fax)
      ipprosecutionsf@orrick.com;beth.goldman@orrick.com;blee@orrick.com;eaghnami@orrick.com;aparker@orrick.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Thomas Ottoboni/   Date: 12/12/2017
Signatory's Name: Thomas Ottoboni
Signatory's Position: Senior VP
Payment Sale Number: 87718146
Payment Accounting Date: 12/13/2017

Serial Number: 87718146
Internet Transmission Date: Tue Dec 12 18:09:38 EST 2017
TEAS Stamp: USPTO/BAS-X.XX.XXX.X-2017121218093848683
3-87718146-51055ddd2128dcbb2275428eb6ca2
447491e8b8a435587f7972f9f03c3848288c-DA-
5656-20171212135024485319

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed